Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patientsMark Sausen, Victor E. Velculescu, Derek Murphy et al.|Nature Communications|2015Cited by 484
The association of genomic lesions and PD-1/PD-L1 expression in resected triple-negative breast cancersMichael T. Barrett, Barbara A. Pockaj|Breast Cancer Research|2018Cited by 84
STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinomaLisa Evers, Michael T. Barrett|Genome Medicine|2014Cited by 28
Resistance signatures to oncolytic vesiculoviruses in pancreatic ductal adenocarcinomaChelsae R Watters, Mitesh J. Borad, Oumar Barro et al.|Molecular Therapy Oncology|2025Cited by 3